Your browser doesn't support javascript.
loading
The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
Dutta, Noton K; Mazumdar, Kaushiki; Gordy, James T.
Affiliation
  • Dutta NK; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA ndutta1@jhmi.edu.
  • Mazumdar K; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Gordy JT; The W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
J Virol ; 94(13)2020 06 16.
Article in En | MEDLINE | ID: mdl-32546606
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronavirus Infections / Severe acute respiratory syndrome-related coronavirus Limits: Humans Language: En Journal: J Virol Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronavirus Infections / Severe acute respiratory syndrome-related coronavirus Limits: Humans Language: En Journal: J Virol Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States